Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ESLA
#3530
Estrella Immunopharma, Inc. Common Stock
1.2
2
+0.83%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.83%
Monthly Change
+10.91%
6 month change
+29.79%
Year Change
+25.77%
Previous Close
1.2
1
Open
1.2
2
Bid
Ask
Low
1.2
2
High
1.2
2
Volume
1
Markets
US Stock Market
Healthcare
ESLA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Total assets
2.44 M
2.98 M
3.52 M
Total liabilities
4.28 M
9.08 M
13.36 M
Total equity
-1.83 M
-6.09 M
-9.84 M
Total liabilities & shareholders' equities
2.44 M
2.98 M
3.52 M
Total debt
—
—
—
Net debt
—
—
—
News
에스트렐라, 림프종 임상시험서 100% 완전반응률 보고
Estrella reports 100% complete response rate in lymphoma trial
에스트렐라, CD19 표적 세포 치료 1상 데이터 발표 예정
Estrella to present phase 1 data on CD19-targeted cell therapy
에스트렐라 이뮤노파마, 나스닥 연례 회의 지연 통지 받아
Estrella Immunopharma receives Nasdaq notice for delayed annual meeting
에스트렐라 이뮤노파마, 800만 달러 규모의 등록 직접 공모 마감
Estrella Immunopharma closes $8 million registered direct offering
에스트렐라 이뮤노파마, 800만 달러 규모 공모 발표 후 주가 하락
Estrella Immunopharma stock falls after announcing $8 million offering
에스트렐라 이뮤노파마, 등록 공모 통해 800만 달러 조달
Estrella Immunopharma raises $8 million through registered offering